- Home
- VANI
VANI
Vivani Medical Inc. (DE)
as 05-09-2025 4:00pm EST
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | ALAMEDA |
| Market Cap: | N/A | IPO Year: | 2014 |
| Target Price: | $4.00 | AVG Volume (30 days): | 40.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.43 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.91 - $2.09 | Next Earning Date: | 05-20-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Vivani Medical Inc. (DE) (VANI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Williams Gregg | VANI | Director10% Owner | Apr 21 '25 | Buy | $1.01 | 1,812 | $1,830.12 | 13,826,799 | |
| Williams Gregg | VANI | Director10% Owner | Apr 9 '25 | Buy | $1.02 | 20,840 | $21,233.69 | 13,826,799 | |
| Williams Gregg | VANI | Director10% Owner | Apr 4 '25 | Buy | $0.99 | 205,482 | $205,258.15 | 13,826,799 | |
| Williams Gregg | VANI | Director10% Owner | Apr 2 '25 | Buy | $1.01 | 24,939 | $24,959.00 | 13,826,799 | |
| Dwyer Donald | VANI | Chief Business Officer | Apr 1 '25 | Buy | $1.03 | 4,000 | $4,100.00 | 55,000 | |
| Dwyer Donald | VANI | Chief Business Officer | Feb 28 '25 | Buy | $1.11 | 1,000 | $1,110.00 | 55,000 |
Latest Vivani Medical Inc. (DE) News
VANI Breaking Stock News: Dive into VANI Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Vivani Medical to Present at the American Association of Pharmaceutical Scientists’ “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop
GlobeNewswire
23 days ago
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
MT Newswires
24 days ago
Vivani Medical, Okava Expand Weight-Loss Drug Collaboration to Include Dogs
GlobeNewswire
24 days ago
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
Benzinga
24 days ago
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs
Simply Wall St.
a month ago
April 2025's Top Penny Stocks To Watch
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 04/07/2025
Associated Press Finance
a month ago
Vivani Medical: Q4 Earnings Snapshot
Compare VANI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VANI Vivani Medical Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.